Bristol Myers (BMY) Wins EC Nod for Reblozyl Label Expansion
https://www.zacks.com/stock/news/2249839/bristol-myers-bmy-wins-ec-nod-for-reblozyl-label-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249839
Apr 03, 2024 - Bristol Myers (BMY) receives European Commission's approval for a label expansion of Reblozyl (luspatercept) for another indication.
0
Ecopetrol (EC) Wins Dispute, Awarded McDermott Share Capital
https://www.zacks.com/stock/news/2246882/ecopetrol-ec-wins-dispute-awarded-mcdermott-share-capital?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2246882
Mar 27, 2024 - Ecopetrol's (EC) Reficar receives the 19.9% convertible preferred shares of McDermott International under a financial restructuring plan proposed by its subsidiary, CB&I N.V.
0
Ecopetrol S.A. (EC) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4675412-ecopetrol-s-ec-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Mar 01, 2024 - Ecopetrol S.A. (NYSE:NYSE:EC) Q4 2023 Earnings Call Transcript March 1, 2024 9:00 AM ETCompany ParticipantsRicardo Roa - CEOAlberto Consuegra - COODavid...
0
Ecopetrol (EC) Gears Up for Q4 Earnings: What's in Store?
https://www.zacks.com/stock/news/2231076/ecopetrol-ec-gears-up-for-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2231076
Feb 23, 2024 - Lower commodity prices are likely to have hurt Ecopetrol's (EC) Q4 earnings to some extent.
0
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
https://www.zacks.com/stock/news/2202251/cidara-cdtx-up-on-ec-nod-for-rezzayo-in-invasive-candidiasis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202251
Dec 26, 2023 - Cidara's (CDTX) Rezzayo (rezafungin acetate) gets approval from the European Commission for the treatment of invasive candidiasis in adults. The stock rises 11.1%.
0
Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now
https://www.zacks.com/stock/news/2202122/why-investors-need-to-take-advantage-of-these-2-oils-and-energy-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2202122
Dec 26, 2023 - The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
0
Here's Why it is Worth Investing in Sunoco (SUN) Stock Now
https://www.zacks.com/stock/news/2201564/here-s-why-it-is-worth-investing-in-sunoco-sun-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2201564
Dec 22, 2023 - Sunoco (SUN) raises its 2023 EBITDA guidance to above $935 million, banking on its continued strong performance.
0
Eni (E) Boosts UK CCS Leadership With CCUS Market Launch
https://www.zacks.com/stock/news/2201565/eni-e-boosts-uk-ccs-leadership-with-ccus-market-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2201565
Dec 22, 2023 - Eni (E) plays a significant role in the expansion of the HyNet Cluster, operating CO2 transport and storage within this initiative.
0
ExxonMobil (XOM) Gets Approval for Hebron Field Expansion
https://www.zacks.com/stock/news/2200931/exxonmobil-xom-gets-approval-for-hebron-field-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2200931
Dec 21, 2023 - This approval grants ExxonMobil (XOM) and its partners the authority to proceed with the development of sands within Jeanne d'Arc Formation.
0
ExxonMobil (XOM) Plans to Pilot CCS With CFC Technology
https://www.zacks.com/stock/news/2199857/exxonmobil-xom-plans-to-pilot-ccs-with-cfc-technology?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2199857
Dec 19, 2023 - ExxonMobil (XOM) intends to construct a pilot plant at its Rotterdam Manufacturing Complex.
0
Pages: 12
Page 1